Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger

Catherine E Handy^{1

2}, Renato Quispe^{2

3}, Xavier Pinto⁴, Michael J Blaha^{2

5}, Roger S Blumenthal², Erin D Michos^{2

5

6}, Joao A C Lima⁷, Eliseo Guallar^{5

6}, Seungho Ryu^{8

9

10}, Juhee Cho^{5

8

11}, James A Kaye¹², Josep Comin-Colet^{13

14}, Xavier Corbella^{15

16}, Miguel Cainzos-Achirica^{2

12

13}

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center (C.E.H.).
² Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology (C.E.H., R.Q., M.J.B., R.S.B., E.D.M., M.C.-A.).
³ Department of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY (R.Q.).
⁴ Cardiovascular Risk Unit, Department of Internal Medicine, Bellvitge University Hospital, Barcelona, Spain (X.P.).
⁵ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (M.J.B., E.D.M., E.G., J.C.).
⁶ Welch Center for Prevention, Epidemiology, and Clinical Research (E.D.M., E.G.), Johns Hopkins University, Baltimore, MD.
⁷ Division of Cardiovascular Imaging (J.A.C.L.), Johns Hopkins School of Medicine, Baltimore, MD.
⁸ Center for Cohort Studies, Total Healthcare Center (S.R., J.C.).
⁹ Department of Occupational and Environmental Medicine (S.R.).
¹⁰ Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea (S.R.).
¹¹ Kangbuk Samsung Hospital, and Center for Clinical Epidemiology, Samsung Medical Center (J.C.), Sungkyunkwan University School of Medicine, Seoul, South Korea.
¹² Research Triangle Institute Health Solutions, Pharmacoepidemiology and Risk Management, Waltham, MA and Barcelona, Spain (J.A.K., M.C.-A.).
¹³ Department of Cardiology, Bellvitge University Hospital and Bellvitge Biomedical Research Institute (Institut d'Investigació Biomèdica de Bellvitge), Barcelona, Spain (J.C.-C., M.C.-A.).
¹⁴ Department of Clinical Sciences, University of Barcelona, Barcelona, Spain (J.C.-C.).
¹⁵ Department of Internal Medicine, Bellvitge University Hospital, Barcelona, Spain (X.C.).
¹⁶ Hestia Chair in Integrated Health and Social Care, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain (X.C.).

PMID: 30359131
DOI: 10.1161/CIRCULATIONAHA.118.035516

Review

Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger

Catherine E Handy et al. Circulation. 2018.

. 2018 Aug 14;138(7):727-734.

doi: 10.1161/CIRCULATIONAHA.118.035516.

Authors

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center (C.E.H.).
² Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology (C.E.H., R.Q., M.J.B., R.S.B., E.D.M., M.C.-A.).
³ Department of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY (R.Q.).
⁴ Cardiovascular Risk Unit, Department of Internal Medicine, Bellvitge University Hospital, Barcelona, Spain (X.P.).
⁵ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (M.J.B., E.D.M., E.G., J.C.).
⁶ Welch Center for Prevention, Epidemiology, and Clinical Research (E.D.M., E.G.), Johns Hopkins University, Baltimore, MD.
⁷ Division of Cardiovascular Imaging (J.A.C.L.), Johns Hopkins School of Medicine, Baltimore, MD.
⁸ Center for Cohort Studies, Total Healthcare Center (S.R., J.C.).
⁹ Department of Occupational and Environmental Medicine (S.R.).
¹⁰ Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea (S.R.).
¹¹ Kangbuk Samsung Hospital, and Center for Clinical Epidemiology, Samsung Medical Center (J.C.), Sungkyunkwan University School of Medicine, Seoul, South Korea.
¹² Research Triangle Institute Health Solutions, Pharmacoepidemiology and Risk Management, Waltham, MA and Barcelona, Spain (J.A.K., M.C.-A.).
¹³ Department of Cardiology, Bellvitge University Hospital and Bellvitge Biomedical Research Institute (Institut d'Investigació Biomèdica de Bellvitge), Barcelona, Spain (J.C.-C., M.C.-A.).
¹⁴ Department of Clinical Sciences, University of Barcelona, Barcelona, Spain (J.C.-C.).
¹⁵ Department of Internal Medicine, Bellvitge University Hospital, Barcelona, Spain (X.C.).
¹⁶ Hestia Chair in Integrated Health and Social Care, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain (X.C.).

PMID: 30359131
DOI: 10.1161/CIRCULATIONAHA.118.035516

Abstract

Cardiovascular disease (CVD) and cancer continue to be the 2 leading causes of death in developed countries despite significant improvements in the prevention, screening, and treatment of both diseases. They remain significant public health problems, growing in importance globally. Despite this threat, the fields of cardiology and oncology have been relatively disconnected. With many shared modifiable risk factors, cancer and CVD often coexist in the same individuals; those diagnosed with lung cancer, breast cancer, and colon cancer are at higher risk of CVD, and those with CVD are at higher risk of developing many types of common cancers. Screening paradigms have been established in parallel, but there are opportunities for combined risk assessments for cancer and CVD risk. Joining forces for combined cardiovascular and hemato-oncological preventive and research efforts will likely have synergistic, worldwide public health benefits.

Keywords: cancer; cardiovascular diseases; prevention; screening.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger

Affiliations

Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger

Authors

Affiliations

Abstract

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical